Artificial Intelligence in Ophthalmology Market | DelveInsight
An in-depth Assessment of the Top Drugs Launched by Leading Global Companies in the First Half of 2021 (H1)
medtech-news-for-cerner-scanwell-zynex-envista-sight-sciences
Cerner, Scanwell Health and Personal ...

Oracle Corporation sets to acquire Cerner Corporation  On December 20, 2021, Oracle Corporation and Ce...

pharma-news-for-edwards-lineage-novartis-koios-medical
Edwards’ Sapien 3 with Alterra Preste...

Edwards secures FDA approval for Sapien 3 with Alterra Prestent for Transcatheter Pulmonic Valve Replacemen...

biosimilar-market-outlook
Analyzing the Growth of the Biosimila...

The expiration of many biologic drugs patents has sparked biosimilar development and boosted the biosimilar...

medtech-news-for-lensgen-ge-nevro-hyperfine-immunexpress
LensGen’s Juvene Intraocular Lens; Nevro announces clinical data publications; FDA Clearance to I...

Canon Medical launches super-resolution deep-learning reconstruction for Cardiac CT scans  On November 28, 2021, Canon Medical launched the Precise IQ Engine (PIQE) DLR and SilverBeam filt...


medtech-news-for-neurent-theradaptive-hagar-fujifilm-brain-navi
Neurent Medical’s NEUROMARK; Brain Navi NaoTrac received European CE Mark approval; Theradaptive ...

Neurent Medical obtains FDA Clearance for NEUROMARK™, a novel multi-point Nerve Disruption Treatment for Chronic Rhinitis   On November 18, 2021, Neurent Medical, a company wor...


medtech-news-and-updates-for-abbott-ivantis-medtronic-alung-appliedvr-orthalign
Abbott’s Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ...

J&J intends to split into two companies, separating consumer products and pharmaceutical businesses  On November 12, 2021, Johnson & Johnson announced its plans to split the Company’s C...


pharma-news-for-astrazeneca-wision-getinge-lumithera
AstraZeneca-Moderna’s AZD8601 VEGF-A mRNA Trial; Wision AI gets CE Mark approval; Getinge a...

AstraZeneca, Moderna announces positive data of mRNA potential in heart failure patients  Moderna, Inc., a biotechnology company is pioneering messenger RNA (mRNA) therapeutics and vaccine...


medtech-news-for-tectraum-vektor-medtronic-alcon-philips-sight-sciences
TecTraum’s pro2cool receives Breakthrough Device Designation; Vektor Obtains FDA Clearance for vM...

TecTraum’s pro2cool® receives FDA Breakthrough Device Designation for the Concussions treatment   On November 03, 2021, TecTraum Inc., working to develop the world’s first point-of-care treatme...


pharma-happenings-for-alcon-philips-bioxcel-penumbra
Alcon to acquire Ivantis; Philips to takeover Cardiologs; Flunked cancer drug progresses in I-O i...

Alcon to acquire Ivantis for USD 475 Million  Alcon announced that it intends to buy glaucoma surgery device maker Ivantis for USD 475 million upfront. Geneva, Switzerland-based Alcon a...


Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...